← Evidence map

ArticleHeliyon2024

Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants.

Delphine Planas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38486776